ACMELAB
AThe ACME Laboratories Limited · Pharmaceuticals & Chemicals
No lists yet
Create on Stocks pageKey Statistics
The ACME Laboratories Limited
Pharmaceuticals & Chemicals sector stock listed on DSE since 2016.
Trading Info
Capital Structure
External Links
Valuation
Dividend History
As declared per DSE audited financial performance, shown as a percentage of face value. May combine cash and bonus. A dash means the year was not reported.
EPS History
Share Distribution
The company has informed that the Board of Directors has appointed Ms. Tasneem Sinha as the Managing Director of the company with effect from August 1...
The company has informed that the Board of Directors has appointed Ms. Tasneem Sinha as the Managing Director of the company with effect from August 10, 2026.
The Company has further informed that 8,574,000 shares of the Company held by Late Mr. Mizanur Rahman Sinha, Sponsor Director and Managing Director of...
The Company has further informed that 8,574,000 shares of the Company held by Late Mr. Mizanur Rahman Sinha, Sponsor Director and Managing Director of the company, have been transmitted to the BO account of his nominees, Ms. Tasneem Sinha, daughter of late Mr. Mizanur Rahman Sinha & Deputy Managing Director of the Company and Mr. Tanveer Sinha, son of late Mr. Mizanur Rahman Sinha & Director of the Company by way of nomination as per the news disseminated by DSE on June 3, 2026.
The Company has informed that Mr. Mizanur Rahman Sinha, Sponsor Director and Managing Director of the company, passed away on May 16, 2026. His holdin...
The Company has informed that Mr. Mizanur Rahman Sinha, Sponsor Director and Managing Director of the company, passed away on May 16, 2026. His holding of 8,574,000 shares of the Company will be transmitted to his nominees by way of nomination as follows: Ms. Tasneem Sinha, daughter of late Mr. Mizanur Rahman Sinha and Deputy Managing Director of the Company will receive 4,287,000 shares. Mr. Tanveer Sinha, son of late Mr. Mizanur Rahman Sinha and Director of the Company will receive 4,287,000 shares.
(Cont. News of ACMELAB): Net operating cash flow per share has been increased due to higher sales collections and lower procurement of materials. In a...
(Cont. News of ACMELAB): Net operating cash flow per share has been increased due to higher sales collections and lower procurement of materials. In addition, finance cost has been decreased while Inventory levels-including materials in transit has also been decreased. (end)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors wil...
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2026 at 3:30 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.
Ms. Parveen Akhter Khanam, Sponsor of the company, has expressed her intention to transfer 740,000 shares of the company to her son Mr. Ansar Uddin Si...
Ms. Parveen Akhter Khanam, Sponsor of the company, has expressed her intention to transfer 740,000 shares of the company to her son Mr. Ansar Uddin Sinha (General Shareholder of the company), by way of gift outside the trading system of the Exchange within thirty working days with effect from March 15, 2026.
(Q2 Un-audited): EPS was Tk. 3.10 for October-December 2025 as against Tk. 2.86 for October-December 2024; EPS was Tk. 6.11 for July-December 2025 as...
(Q2 Un-audited): EPS was Tk. 3.10 for October-December 2025 as against Tk. 2.86 for October-December 2024; EPS was Tk. 6.11 for July-December 2025 as against Tk. 5.47 for July-December 2024. NOCFPS was Tk. 12.16 for July-December 2025 as against Tk. 6.85 (Restated) for July-December 2024. NAV per share was Tk. 128.97 as on December 31, 2025 and Tk. 126.37 as on June 30, 2025.
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors wil...
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2026 at 3:45 PM to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended December 31, 2025.
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
Credit Rating Information and Services PLC (CRISL) has assigned the rating of the Company as "AA" in the long term and "ST-2" in the short term along...
Credit Rating Information and Services PLC (CRISL) has assigned the rating of the Company as "AA" in the long term and "ST-2" in the short term along with Stable outlook in consideration of its audited financials up to June 30, 2025 also unaudited financials up to September 30, 2025 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
Momentum
Price ৳77.50Fell hard — often bounces
-1.28 · signal -1.09 · hist -0.18
Price vs averages
Go Deeper on This Stock
RSI, MACD, Bollinger Bands, and 12+ indicators — calculated and ready for every listed stock.
Compare PlansBlock Trades
See What Big Investors Traded Today
Block transactions reveal institutional buying and selling that don't show up in regular price data.
Compare Plans